CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Exercise or conversion Director acquired 60,698 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 7,201 shares (gift)
- 4 Open-market sale Director sold 30,000 shares at $7.85 ($235,500)
- 4 Exercise or conversion Director acquired 14,403 shares (option exercise)
- 4 Exercise or conversion Director acquired 12,345 shares (option exercise)
- 4 Exercise or conversion Director acquired 12,345 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 11,938 shares at $7.65 ($91,338)
- 4 Open-market sale Director sold 18,062 shares at an average $7.93 ($143,156)
- 4 Exercise or conversion President & CEO acquired 12,345 shares (option exercise)
- 4 Open-market buy CFO & COO bought 5,300 shares at an average $6.22 ($32,940)
Page 14 of 19 · 370 filings